Mylan Pharmaceuticals Inc recalls Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol, 10 g aerosol containers, Rx Only,…
cGMP deficiencies
Read the official notice →- Date
- 2022-02-02
- Country
- United States
- Brand
- Mylan Pharmaceuticals
- Product
- Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol, 10 g aerosol containers, Rx Only, Distributed by…
- Classification
- Class II
- Units
- Recalled product was distributed nationwide within the United States.
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Mylan Pharmaceuticals recalls
- 2025-03-26
USMYLAN PHARMACEUTICALS INC recalls Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC…
Failed Dissolution Specifications - low dissolution results
- 2022-08-03
- US
Mylan Pharmaceuticals Inc recalls Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons…
Labeling: Missing label: Label missing from some prefilled pens.
FDA · DrugMylan Pharmaceuticals IncProduct was distributed nationwide within the United StatesOfficial notice → - 2022-05-04
- US
- 2022-04-27
- US
Mylan Pharmaceuticals Inc recalls Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505…
Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.
- 2022-04-13
- US
Mylan Pharmaceuticals Inc recalls Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV…
Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related substance impurities/degradation during routine…
- 2022-01-26
- US
Mylan Pharmaceuticals Inc recalls Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3 mL Prefilled…
Labeling: Missing Label: label missing from some Semglee prefilled pens.
Other drugs & medical recalls in the United States
- 2022-02-02
- US
Siemens Medical Solutions USA, Inc recalls Artis pheno with software VE20C- diagnostic imaging angiography system Model: 10849000
Four potential software issues with Artis pheno and Artis icono systems with software VE20C: 1. Updated calibration data not saved with measurement after scene+/-; 2. No x-ray possible, system shutdown/restart might be…
- US
Philips Respironics, Inc. recalls Trilogy Evo, Material Numbers DS2110X11B (USA) and KR2110X15B (Korea) The Trilogy Evo ventilator provides continuous or intermittent…
Philips has identified a specific lot of non-conforming material manufactured by one of its suppliers. A Philips supplier incorrectly used polyester-based polyurethane (PE-PUR) sound abatement foam, a non-conforming…
FDA · DevicePhilips Respironics, Inc.Worldwide Distribution: Distributed to the following US states: AR, CO, FL,…Official notice → - US
Dental Alliance Holdings LLC recalls CTx7 Kit, contains one tube CariFree CTx4 Gel 5000, 1.1% Neutral Sodium Fluoride Mint, 2 oz (57 g) Rx only NDC: 61578-205-01…
Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.
FDA · DrugDental Alliance Holdings LLCDistributed nationwide with the United StatesOfficial notice → - US
- US
Aurobindo Pharma USA Inc. recalls Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05
Superpotent and Failed Tablet/Capsule Specifications
- US